MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Evaluation of the short-term and long-term effects of an intensive multidisciplinary collective rehabilitation program over 5 weeks in Parkinson’s patients followed in Lyon

    T. DANAILA, C. LAURENCIN, P. ROCHE, S. THOBOIS, M. CHEMINON, J. LUAUTE (BRON, France)

  • Event-related potentials and mild cognitive impairment in Parkinson’s disease.

    J. Pagonabarraga, J. Marin-Lahoz, A. Horta, M. Cornella, H. Bejr-Kasem, S. Martinez-Horta, J. Pérez-Pérez, M.Á. Boti, J. Kulisevsky (Barcelona, Spain)

  • Evidence of putaminal petechial hemorrhage as the cause of hyperglycemic chorea

    J.-J. Lin (Nantou, Taiwan)

  • Evidence-based Brazilian Physicaltherapy Guideline for Huntington´s Disease

    T. Capato, M. Haddad, E. Barbosa, M.E. Piemonte (Sao Paulo, Brazil)

  • Evolution in Dopamine Transporter (DaT) Scan Utilization Patterns and its Effect on Treatment Decisions:  Results of the Next 200 Scans

    X.X. Yu (Cleveland, OH, USA)

  • Evolution of Globus Pallidus Internus (GPi) Deep Brain Stimulation Targeting Over 15 Years

    V. Holanda, L. Almeida, M. Okun, A. Patterson, W. Deeb, A. Shukla, K. Foote (Gainesville, FL, USA)

  • Examining central cognitive processing speed as an early marker of Huntington’s disease (HD) onset

    A. Nathan, S. Park, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)

  • Examining the brain reserve hypothesis in Parkinson’s disease

    P.C. Lee, F. Artaud, F. Cormier, O. Rascol, F. Durif, P. Derkinderen, F. Bourdain, J.-P. Brandel, F. Pico, L. Lacomblez, C. Bonnet, D. Grabli, S. Klebe, G. Mangone, H. You, V. Mesnage, A. Brice, M. Vidailhet, J.-C. Corvol, A. Elbaz (Taipei, Taiwan)

  • Excellent Non-motor Responses after Bilateral Subthalamic Deep Brain Stimulation in Parkinson’s Disease Patient with SNCA Duplication

    J. Youn, J.W. Cho, J.-I. Lee (Seoul, Republic of Korea)

  • Excessive daytime sleepiness in Parkinson’s disease: risk factors and clinical associations

    O. Babkina, O. Levin, M. Poluektov (Moscow, Russian Federation)

  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • …
  • 155
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley